SWOG S0925: A randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer

Evan Y. Yu*, Hongli Li, Celestia S. Higano, Neeraj Agarwal, Sumanta K. Pal, Ajjai Alva, Elisabeth I. Heath, Elaine T. Lam, Shilpa Gupta, Michael B. Lilly, Yoshio Inoue, Kim N. Chi, Nicholas J. Vogelzang, David I. Quinn, Heather H. Cheng, Stephen R. Plymate, Maha Hussain, Catherine M. Tangen, Ian M. Thompson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S0925: A randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology